{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:12:04Z","timestamp":1768770724030,"version":"3.49.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00428-017-2133-z","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T02:09:48Z","timestamp":1493690988000},"page":"627-637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma"],"prefix":"10.1007","volume":"470","author":[{"given":"Fabian Dominik","family":"Mairinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Flom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Schmeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Borchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wessolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremias","family":"Wohlschlaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mairinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Christian","family":"Christoph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt Werner","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Fred Henry","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"issue":"1","key":"2133_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","volume":"4","author":"RK Goudar","year":"2008","unstructured":"Goudar RK (2008) Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma. Ther Clin Risk Manag 4(1):205\u2013211","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"2133_CR2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/thorax.58.3.198","volume":"58","author":"Z Liu","year":"2003","unstructured":"Liu Z, Klominek J (2003) Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors. Thorax 58(3):198\u2013203","journal-title":"Thorax"},{"issue":"3","key":"2133_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","volume":"113","author":"JE Herndon","year":"1998","unstructured":"Herndon JE et al (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113(3):723\u2013731","journal-title":"Chest"},{"issue":"9","key":"2133_CR4","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","volume":"24","author":"GL Ceresoli","year":"2006","unstructured":"Ceresoli GL et al (2006) Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol 24(9):1443\u20131448","journal-title":"J Clin Oncol"},{"issue":"3","key":"2133_CR5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bjc.2013.368","volume":"109","author":"GL Ceresoli","year":"2013","unstructured":"Ceresoli GL et al (2013) Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma. Br J Cancer 109(3):552\u2013558","journal-title":"Br J Cancer"},{"issue":"1","key":"2133_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","volume":"99","author":"GL Ceresoli","year":"2008","unstructured":"Ceresoli GL et al (2008) Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials. Br J Cancer 99(1):51\u201356","journal-title":"Br J Cancer"},{"issue":"8","key":"2133_CR7","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","volume":"17","author":"PA Zucali","year":"2011","unstructured":"Zucali PA et al (2011) Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin. Clin Cancer Res 17(8):2581\u20132590","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"2133_CR8","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.lungcan.2004.04.020","volume":"45","author":"S Tomek","year":"2004","unstructured":"Tomek S, Manegold C (2004) Chemotherapy for malignant pleural mesothelioma: past results and recent developments. Lung Cancer 45(Suppl 1):S103\u2013S119","journal-title":"Lung Cancer"},{"issue":"2","key":"2133_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6600673","volume":"88","author":"S Tomek","year":"2003","unstructured":"Tomek S et al (2003) Chemotherapy for malignant pleural mesothelioma: past results and recent developments. Br J Cancer 88(2):167\u2013174","journal-title":"Br J Cancer"},{"issue":"4","key":"2133_CR10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/107327480301000404","volume":"10","author":"R Rosell","year":"2003","unstructured":"Rosell R et al (2003) Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer. Cancer Control 10(4):297\u2013305","journal-title":"Cancer Control"},{"issue":"4","key":"2133_CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MCP.0b013e32816b5c63","volume":"13","author":"KA Olaussen","year":"2007","unstructured":"Olaussen KA, Mountzios G, Soria JC (2007) ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer. Curr Opin Pulm Med 13(4):284\u2013289","journal-title":"Curr Opin Pulm Med"},{"issue":"10","key":"2133_CR12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/JTO.0b013e318155a637","volume":"2","author":"R Booton","year":"2007","unstructured":"Booton R et al (2007) ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer. J Thorac Oncol 2(10):902\u2013906","journal-title":"J Thorac Oncol"},{"issue":"17","key":"2133_CR13","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-11-0790","volume":"17","author":"L Friboulet","year":"2011","unstructured":"Friboulet L et al (2011) Molecular characteristics of ERCC1-negative versus ERCC1-positive tumors in resected NSCLC. Clin Cancer Res 17(17):5562\u20135572","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2133_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.lungcan.2007.08.025","volume":"59","author":"T Fujii","year":"2008","unstructured":"Fujii T et al (2008) ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer. Lung Cancer 59(3):377\u2013384","journal-title":"Lung Cancer"},{"issue":"10","key":"2133_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025164","volume":"6","author":"RA Hubner","year":"2011","unstructured":"Hubner RA et al (2011) Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations. PLoS One 6(10):e25164","journal-title":"PLoS One"},{"issue":"1","key":"2133_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JTO.0b013e318233d6a9","volume":"7","author":"ZG Zimling","year":"2012","unstructured":"Zimling ZG et al (2012) Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival. J Thorac Oncol 7(1):249\u2013256","journal-title":"J Thorac Oncol"},{"issue":"17","key":"2133_CR17","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1158\/0008-5472.CAN-09-1237","volume":"69","author":"NR Bhagwat","year":"2009","unstructured":"Bhagwat NR et al (2009) Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res 69(17):6831\u20136838","journal-title":"Cancer Res"},{"issue":"4","key":"2133_CR18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2559.2011.03854.x","volume":"60","author":"KM Kerr","year":"2012","unstructured":"Kerr KM (2012) Personalized medicine for lung cancer: new challenges for pathology. Histopathology 60(4):531\u2013546","journal-title":"Histopathology"},{"issue":"4","key":"2133_CR19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1078-0432.CCR-09-2204","volume":"16","author":"NS Kamal","year":"2010","unstructured":"Kamal NS et al (2010) MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer. Clin Cancer Res 16(4):1206\u20131215","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2133_CR20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cllc.2013.04.013","volume":"14","author":"S Ting","year":"2013","unstructured":"Ting S et al (2013) ERCC1, MLH1, MSH2, MSH6, and betaIII-tubulin: resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma. Clin Lung Cancer 14(5):558\u2013567 e3","journal-title":"Clin Lung Cancer"},{"issue":"13","key":"2133_CR21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.7150\/jca.16390","volume":"7","author":"RF Walter","year":"2016","unstructured":"Walter RF et al (2016) Screening of pleural mesotheliomas for DNA-damage repair players by digital gene expression analysis can enhance clinical management of patients receiving platin-based chemotherapy. J Cancer 7(13):1915\u20131925","journal-title":"J Cancer"},{"issue":"3","key":"2133_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK et al (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26(3):317\u2013325","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2133_CR23","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/bioinformatics\/bts188","volume":"28","author":"D Waggott","year":"2012","unstructured":"Waggott D et al (2012) NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics 28(11):1546\u20131548","journal-title":"Bioinformatics"},{"key":"2133_CR24","doi-asserted-by":"crossref","unstructured":"Walter RF et al (2015) Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis. Oncotarget","DOI":"10.18632\/oncotarget.3992"},{"issue":"7","key":"2133_CR25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2217\/fon.15.18","volume":"11","author":"RF Walter","year":"2015","unstructured":"Walter RF et al (2015) SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString). Future Oncol 11(7):1027\u20131036","journal-title":"Future Oncol"},{"issue":"6","key":"2133_CR26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7150\/jca.9235","volume":"5","author":"FD Mairinger","year":"2014","unstructured":"Mairinger FD et al (2014) Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesis. J Cancer 5(6):465\u2013471","journal-title":"J Cancer"},{"key":"2133_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6750-11-46","volume":"11","author":"PP Reis","year":"2011","unstructured":"Reis PP et al (2011) mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol 11:46","journal-title":"BMC Biotechnol"},{"issue":"15","key":"2133_CR28","doi-asserted-by":"crossref","first-page":"20166","DOI":"10.18632\/oncotarget.7737","volume":"7","author":"RF Walter","year":"2016","unstructured":"Walter RF et al (2016) Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome. Oncotarget 7(15):20166\u201320179","journal-title":"Oncotarget"},{"issue":"14","key":"2133_CR29","doi-asserted-by":"crossref","first-page":"18713","DOI":"10.18632\/oncotarget.7666","volume":"7","author":"RF Walter","year":"2016","unstructured":"Walter RF et al (2016) microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma. Oncotarget 7(14):18713\u201318721","journal-title":"Oncotarget"},{"issue":"Web Server issu","key":"2133_CR30","doi-asserted-by":"crossref","first-page":"W145","DOI":"10.1093\/nar\/gkr294","volume":"39","author":"M Maragkakis","year":"2011","unstructured":"Maragkakis M et al (2011) DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to disease association. Nucleic Acids Res 39(Web Server issue):W145\u2013W148","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2133_CR31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng1910","volume":"38","author":"K Chen","year":"2006","unstructured":"Chen K, Rajewsky N (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38(12):1452\u20131456","journal-title":"Nat Genet"},{"key":"2133_CR32","doi-asserted-by":"crossref","unstructured":"Agarwal V et al (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4","DOI":"10.7554\/eLife.05005"},{"issue":"W1","key":"2133_CR33","doi-asserted-by":"crossref","first-page":"W460","DOI":"10.1093\/nar\/gkv403","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos IS et al (2015) DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 43(W1):W460\u2013W466","journal-title":"Nucleic Acids Res"},{"key":"2133_CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4939-1062-5_25","volume":"1182","author":"H Dweep","year":"2014","unstructured":"Dweep H, Gretz N, Sticht C (2014) miRWalk database for miRNA-target interactions. Methods Mol Biol 1182:289\u2013305","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2133_CR35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.lungcan.2011.04.014","volume":"73","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Sharon E, Hassan R (2011) Chemotherapy and targeted therapies for unresectable malignant mesothelioma. Lung Cancer 73(3):256\u2013263","journal-title":"Lung Cancer"},{"issue":"5","key":"2133_CR36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","volume":"6","author":"V Balatti","year":"2011","unstructured":"Balatti V et al (2011) MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol 6(5):844\u2013851","journal-title":"J Thorac Oncol"},{"issue":"3","key":"2133_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","volume":"42","author":"S Busacca","year":"2010","unstructured":"Busacca S et al (2010) MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol 42(3):312\u2013319","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"2133_CR38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170999","volume":"12","author":"C De Santi","year":"2017","unstructured":"De Santi C et al (2017) Identification of Mir-21-5p as a functional regulator of mesothelin expression using microRNA capture affinity coupled with next generation sequencing. PLoS One 12(1):e0170999","journal-title":"PLoS One"},{"issue":"3","key":"2133_CR39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","volume":"9","author":"MB Kirschner","year":"2015","unstructured":"Kirschner MB et al (2015) MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Mol Oncol 9(3):715\u2013726","journal-title":"Mol Oncol"},{"issue":"1","key":"2133_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncy.21646","volume":"124","author":"R Cappellesso","year":"2016","unstructured":"Cappellesso R et al (2016) Young investigator challenge: microRNA-21\/microRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology. Cancer Cytopathol 124(1):28\u201337","journal-title":"Cancer Cytopathol"},{"key":"2133_CR41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gdata.2016.06.009","volume":"9","author":"RC Lin","year":"2016","unstructured":"Lin RC et al (2016) MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients. Genom Data 9:44\u201349","journal-title":"Genom Data"},{"key":"2133_CR42","first-page":"635748","volume":"2015","author":"G Ak","year":"2015","unstructured":"Ak G et al (2015) MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion. Biomed Res Int 2015:635748","journal-title":"Biomed Res Int"},{"issue":"50","key":"2133_CR43","doi-asserted-by":"crossref","first-page":"82700","DOI":"10.18632\/oncotarget.12408","volume":"7","author":"I Bononi","year":"2016","unstructured":"Bononi I et al (2016) Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers. Oncotarget 7(50):82700\u201382711","journal-title":"Oncotarget"},{"issue":"2","key":"2133_CR44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","volume":"68","author":"H Yang","year":"2008","unstructured":"Yang H et al (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68(2):425\u2013433","journal-title":"Cancer Res"},{"issue":"1","key":"2133_CR45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-016-0529-z","volume":"15","author":"YY Cheng","year":"2016","unstructured":"Cheng YY et al (2016) KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Mol Cancer 15(1):44","journal-title":"Mol Cancer"},{"issue":"1","key":"2133_CR46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/MCB.01024-12","volume":"33","author":"WT Chen","year":"2013","unstructured":"Chen WT et al (2013) Systematic identification of functional residues in mammalian histone H2AX. Mol Cell Biol 33(1):111\u2013126","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2133_CR47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jb\/mvu021","volume":"156","author":"T Katsube","year":"2014","unstructured":"Katsube T et al (2014) Most hydrogen peroxide-induced histone H2AX phosphorylation is mediated by ATR and is not dependent on DNA double-strand breaks. J Biochem 156(2):85\u201395","journal-title":"J Biochem"},{"issue":"7","key":"2133_CR48","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1158\/1078-0432.CCR-07-1520","volume":"14","author":"T Okazaki","year":"2008","unstructured":"Okazaki T et al (2008) Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clin Cancer Res 14(7):2042\u20132048","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2133_CR49","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1124\/mol.105.012716","volume":"68","author":"LM Karnitz","year":"2005","unstructured":"Karnitz LM et al (2005) Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. Mol Pharmacol 68(6):1636\u20131644","journal-title":"Mol Pharmacol"},{"issue":"15","key":"2133_CR50","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1158\/0008-5472.CAN-04-2246","volume":"65","author":"MA Morgan","year":"2005","unstructured":"Morgan MA et al (2005) Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res 65(15):6835\u20136842","journal-title":"Cancer Res"},{"issue":"2","key":"2133_CR51","first-page":"425","volume":"18","author":"T Papp","year":"2001","unstructured":"Papp T et al (2001) Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas. Int J Oncol 18(2):425\u2013433","journal-title":"Int J Oncol"},{"issue":"6","key":"2133_CR52","first-page":"1375","volume":"8","author":"T Papp","year":"2001","unstructured":"Papp T et al (2001) Mutational analysis of the PTEN\/MMAC1 tumour suppressor gene in primary human malignant mesotheliomas. Oncol Rep 8(6):1375\u20131379","journal-title":"Oncol Rep"},{"issue":"1","key":"2133_CR53","first-page":"1","volume":"62","author":"S Toyooka","year":"2008","unstructured":"Toyooka S, Kishimoto T, Date H (2008) Advances in the molecular biology of malignant mesothelioma. Acta Med Okayama 62(1):1\u20137","journal-title":"Acta Med Okayama"},{"issue":"3","key":"2133_CR54","first-page":"743","volume":"14","author":"K Kumar","year":"2005","unstructured":"Kumar K et al (2005) Mutational analysis of 9 different tumour-associated genes in human malignant mesothelioma cell lines. Oncol Rep 14(3):743\u2013750","journal-title":"Oncol Rep"},{"issue":"6553","key":"2133_CR55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/378206a0","volume":"378","author":"SN Jones","year":"1995","unstructured":"Jones SN et al (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378(6553):206\u2013208","journal-title":"Nature"},{"issue":"6","key":"2133_CR56","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.cdd.4401912","volume":"13","author":"JC Marine","year":"2006","unstructured":"Marine JC et al (2006) Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 13(6):927\u2013934","journal-title":"Cell Death Differ"},{"issue":"6553","key":"2133_CR57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/378203a0","volume":"378","author":"R Montes de Oca Luna","year":"1995","unstructured":"Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378(6553):203\u2013206","journal-title":"Nature"},{"issue":"1","key":"2133_CR58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng714","volume":"29","author":"J Parant","year":"2001","unstructured":"Parant J et al (2001) Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 29(1):92\u201395","journal-title":"Nat Genet"},{"issue":"6","key":"2133_CR59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2006.10.010","volume":"10","author":"I Ringshausen","year":"2006","unstructured":"Ringshausen I et al (2006) Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell 10(6):501\u2013514","journal-title":"Cancer Cell"},{"issue":"12","key":"2133_CR60","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrc2012","volume":"6","author":"F Toledo","year":"2006","unstructured":"Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6(12):909\u2013923","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2133_CR61","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2217\/fon.13.261","volume":"10","author":"FD Mairinger","year":"2014","unstructured":"Mairinger FD et al (2014) Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma. Future Oncol 10(6):995\u20131005","journal-title":"Future Oncol"},{"issue":"5","key":"2133_CR62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bjc.2015.27","volume":"112","author":"RF Walter","year":"2015","unstructured":"Walter RF et al (2015) MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14\/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53. Br J Cancer 112(5):883\u2013890","journal-title":"Br J Cancer"},{"issue":"6","key":"2133_CR63","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2133.2009.09079.x","volume":"160","author":"P Kanellou","year":"2009","unstructured":"Kanellou P et al (2009) Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Br J Dermatol 160(6):1215\u20131221","journal-title":"Br J Dermatol"},{"issue":"7","key":"2133_CR64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2005.03.037","volume":"121","author":"D Chen","year":"2005","unstructured":"Chen D et al (2005) ARF-BP1\/Mule is a critical mediator of the ARF tumor suppressor. Cell 121(7):1071\u20131083","journal-title":"Cell"},{"issue":"5","key":"2133_CR65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/onc.2009.372","volume":"29","author":"L Miao","year":"2010","unstructured":"Miao L et al (2010) ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation. Oncogene 29(5):711\u2013722","journal-title":"Oncogene"},{"issue":"13","key":"2133_CR66","first-page":"3646","volume":"63","author":"Y Huang","year":"2003","unstructured":"Huang Y et al (2003) Enhanced tumor suppression by a p14ARF\/p53 bicistronic adenovirus through increased p53 protein translation and stability. Cancer Res 63(13):3646\u20133653","journal-title":"Cancer Res"},{"issue":"6","key":"2133_CR67","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1158\/1535-7163.MCT-10-1090","volume":"10","author":"T Van Maerken","year":"2011","unstructured":"Van Maerken T et al (2011) Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3. Mol Cancer Ther 10(6):983\u2013993","journal-title":"Mol Cancer Ther"},{"issue":"Suppl 5","key":"2133_CR68","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1289\/ehp.97105s51073","volume":"105","author":"MC Jaurand","year":"1997","unstructured":"Jaurand MC (1997) Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 105(Suppl 5):1073\u20131084","journal-title":"Environ Health Perspect"},{"issue":"2","key":"2133_CR69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1098-2280(1999)33:2<153::AID-EM7>3.0.CO;2-Q","volume":"33","author":"T Ollikainen","year":"1999","unstructured":"Ollikainen T, Linnainmaa K, Kinnula VL (1999) DNA single strand breaks induced by asbestos fibers in human pleural mesothelial cells in vitro. Environ Mol Mutagen 33(2):153\u2013160","journal-title":"Environ Mol Mutagen"},{"issue":"8","key":"2133_CR70","first-page":"3080","volume":"9","author":"S Singhal","year":"2003","unstructured":"Singhal S et al (2003) Gene expression profiling of malignant mesothelioma. Clin Cancer Res 9(8):3080\u20133097","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2133_CR71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lungcan.2009.03.016","volume":"67","author":"OD Roe","year":"2010","unstructured":"Roe OD et al (2010) Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets. Lung Cancer 67(1):57\u201368","journal-title":"Lung Cancer"},{"issue":"Pt 1","key":"2133_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3250001","volume":"325","author":"HE Krokan","year":"1997","unstructured":"Krokan HE, Standal R, Slupphaug G (1997) DNA glycosylases in the base excision repair of DNA. Biochem J 325(Pt 1):1\u201316","journal-title":"Biochem J"},{"issue":"28","key":"2133_CR73","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.1006542107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H et al (2010) Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A 107(28):12611\u201312616","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2133_CR74","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1172\/JCI119010","volume":"98","author":"VC Broaddus","year":"1996","unstructured":"Broaddus VC et al (1996) Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 98(9):2050\u20132059","journal-title":"J Clin Invest"},{"issue":"6","key":"2133_CR75","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/153537020322800602","volume":"228","author":"D Upadhyay","year":"2003","unstructured":"Upadhyay D, Kamp DW (2003) Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med (Maywood) 228(6):650\u2013659","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2133_CR76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1383-5718(00)00093-0","volume":"470","author":"T Ollikainen","year":"2000","unstructured":"Ollikainen T et al (2000) Modulation of cell and DNA damage by poly(ADP)ribose polymerase in lung cells exposed to H(2)O(2) or asbestos fibres. Mutat Res 470(1):77\u201384","journal-title":"Mutat Res"},{"issue":"2","key":"2133_CR77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2011.08.021","volume":"312","author":"D Toumpanakis","year":"2011","unstructured":"Toumpanakis D, Theocharis SE (2011) DNA repair systems in malignant mesothelioma. Cancer Lett 312(2):143\u2013149","journal-title":"Cancer Lett"},{"issue":"18","key":"2133_CR78","first-page":"4349","volume":"53","author":"T Taguchi","year":"1993","unstructured":"Taguchi T et al (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53(18):4349\u20134355","journal-title":"Cancer Res"},{"issue":"6","key":"2133_CR79","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1510\/icvts.2008.181099","volume":"7","author":"S Neragi-Miandoab","year":"2008","unstructured":"Neragi-Miandoab S, Weiner S, Sugarbaker DJ (2008) Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg 7(6):1039\u20131042","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"2133_CR80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/cr.2007.111","volume":"18","author":"M Shrivastav","year":"2008","unstructured":"Shrivastav M, De Haro LP, Nickoloff JA (2008) Regulation of DNA double-strand break repair pathway choice. Cell Res 18(1):134\u2013147","journal-title":"Cell Res"},{"key":"2133_CR81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1476-4598-9-314","volume":"9","author":"A Shukla","year":"2010","unstructured":"Shukla A et al (2010) Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Mol Cancer 9:314","journal-title":"Mol Cancer"},{"issue":"2","key":"2133_CR82","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0027-5107(95)00069-U","volume":"331","author":"HY Dong","year":"1995","unstructured":"Dong HY et al (1995) Synthesis of poly(ADP-ribose) in asbestos treated rat pleural mesothelial cells in culture. Mutat Res 331(2):197\u2013204","journal-title":"Mutat Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-017-2133-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2133-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2133-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T15:00:45Z","timestamp":1569164445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-017-2133-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1007\/s00428-017-2133-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}